NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE208119 Query DataSets for GSE208119
Status Public on Jul 19, 2022
Title A novel prognostic risk model for cervical cancer based on immune checkpoint HLA-G-driven differentially expressed genes
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Jul 13, 2022
Last update date Jul 19, 2022
Contact name Hui-Hui Xu
E-mail(s) xuhh@enzemed.com
Phone +86-13757609637
Organization name Taizhou Hospital
Street address 150
City Linhai
State/province Zhejiang province
ZIP/Postal code 317000
Country China
 
Platforms (1)
GPL23227 BGISEQ-500 (Homo sapiens)
Samples (12)
GSM6337713 HeLa, pv, 1
GSM6337714 HeLa, pv, 2
GSM6337715 HeLa, pv, 3
This SuperSeries is composed of the following SubSeries:
GSE208117 A novel prognostic risk model for cervical cancer based on immune checkpoint HLA-G-driven differentially expressed genes [HeLa]
GSE208118 A novel prognostic risk model for cervical cancer based on immune checkpoint HLA-G-driven differentially expressed genes [SiHa]
Relations
BioProject PRJNA858416

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary data files not provided
SRA Run SelectorHelp

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap